Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation

Saved in:
Bibliographic Details
Published in:Blood 2002-10, Vol.100 (7), p.2679-2680
Main Authors: Wiesmann, Anne, Weissert, Robert, Kanz, Lothar, Einsele, Hermann
Format: Article
Language:English
Subjects:
Adult
Combined Modality Therapy
Drug Therapy, Combination
Humans
Ifosfamide - therapeutic use
Melphalan - therapeutic use
POEMS Syndrome - drug therapy
POEMS Syndrome - physiopathology
POEMS Syndrome - therapy
Prednisolone - therapeutic use
Stem Cell Transplantation
Time Factors
Transplantation, Autologous
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263
cites cdi_FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263
container_end_page 2680
container_issue 7
container_start_page 2679
container_title Blood
container_volume 100
creator Wiesmann, Anne
Weissert, Robert
Kanz, Lothar
Einsele, Hermann
description
doi_str_mv 10.1182/blood-2002-07-2030
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2002_07_2030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120573114</els_id><sourcerecordid>S0006497120573114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263</originalsourceid><addsrcrecordid>eNp9kN1q3DAQhUVpaLZpX6AXRS-gdvSzaxl6U0L6A1sSaHstZHnkdZElI8kN-wx56Xizgd71aobhnDOHj5B3HD5wrsXHLqTUMwEgGDTrlPCCbPhWaLae4CXZAMCOqbbhl-R1KX8AuJJi-4pcciF30Gq1IQ_7FAdWMU_UpxDSPVtmmiK1dLZ1xFjp_VgPdIwuTXPAivTu9ubHT1qOsc9pQrrEHvOQxjjQwzgcWJ8K0nrAbOcjtbGndqkppCEthT4VpqXiRB2GQGu2sczBxrr-SvENufA2FHz7PK_I7y83v66_sf3t1-_Xn_fMCQ3AdCe2baskeC-FUuiFsL4Ru8avK_fC6W2jbddpYaUU2LTAJW-tdlwppcVOXhFxznU5lZLRmzmPk81Hw8GcyJqnouZE1kBjTmRX0_uzaV66Cft_lmeUq-DTWYBr9b8jZlPcCtBhP2Z01fRp_F_-IzJNi8k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation</title><source>ScienceDirect - Connect here FIRST to enable access</source><creator>Wiesmann, Anne ; Weissert, Robert ; Kanz, Lothar ; Einsele, Hermann</creator><creatorcontrib>Wiesmann, Anne ; Weissert, Robert ; Kanz, Lothar ; Einsele, Hermann</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2002-07-2030</identifier><identifier>PMID: 12360984</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Combined Modality Therapy ; Drug Therapy, Combination ; Humans ; Ifosfamide - therapeutic use ; Melphalan - therapeutic use ; POEMS Syndrome - drug therapy ; POEMS Syndrome - physiopathology ; POEMS Syndrome - therapy ; Prednisolone - therapeutic use ; Stem Cell Transplantation ; Time Factors ; Transplantation, Autologous ; Treatment Outcome</subject><ispartof>Blood, 2002-10, Vol.100 (7), p.2679-2680</ispartof><rights>2002 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263</citedby><cites>FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497120573114$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45779</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12360984$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiesmann, Anne</creatorcontrib><creatorcontrib>Weissert, Robert</creatorcontrib><creatorcontrib>Kanz, Lothar</creatorcontrib><creatorcontrib>Einsele, Hermann</creatorcontrib><title>Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation</title><title>Blood</title><addtitle>Blood</addtitle><subject>Adult</subject><subject>Combined Modality Therapy</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Ifosfamide - therapeutic use</subject><subject>Melphalan - therapeutic use</subject><subject>POEMS Syndrome - drug therapy</subject><subject>POEMS Syndrome - physiopathology</subject><subject>POEMS Syndrome - therapy</subject><subject>Prednisolone - therapeutic use</subject><subject>Stem Cell Transplantation</subject><subject>Time Factors</subject><subject>Transplantation, Autologous</subject><subject>Treatment Outcome</subject><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kN1q3DAQhUVpaLZpX6AXRS-gdvSzaxl6U0L6A1sSaHstZHnkdZElI8kN-wx56Xizgd71aobhnDOHj5B3HD5wrsXHLqTUMwEgGDTrlPCCbPhWaLae4CXZAMCOqbbhl-R1KX8AuJJi-4pcciF30Gq1IQ_7FAdWMU_UpxDSPVtmmiK1dLZ1xFjp_VgPdIwuTXPAivTu9ubHT1qOsc9pQrrEHvOQxjjQwzgcWJ8K0nrAbOcjtbGndqkppCEthT4VpqXiRB2GQGu2sczBxrr-SvENufA2FHz7PK_I7y83v66_sf3t1-_Xn_fMCQ3AdCe2baskeC-FUuiFsL4Ru8avK_fC6W2jbddpYaUU2LTAJW-tdlwppcVOXhFxznU5lZLRmzmPk81Hw8GcyJqnouZE1kBjTmRX0_uzaV66Cft_lmeUq-DTWYBr9b8jZlPcCtBhP2Z01fRp_F_-IzJNi8k</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>Wiesmann, Anne</creator><creator>Weissert, Robert</creator><creator>Kanz, Lothar</creator><creator>Einsele, Hermann</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20021001</creationdate><title>Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation</title><author>Wiesmann, Anne ; Weissert, Robert ; Kanz, Lothar ; Einsele, Hermann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Combined Modality Therapy</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Ifosfamide - therapeutic use</topic><topic>Melphalan - therapeutic use</topic><topic>POEMS Syndrome - drug therapy</topic><topic>POEMS Syndrome - physiopathology</topic><topic>POEMS Syndrome - therapy</topic><topic>Prednisolone - therapeutic use</topic><topic>Stem Cell Transplantation</topic><topic>Time Factors</topic><topic>Transplantation, Autologous</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiesmann, Anne</creatorcontrib><creatorcontrib>Weissert, Robert</creatorcontrib><creatorcontrib>Kanz, Lothar</creatorcontrib><creatorcontrib>Einsele, Hermann</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiesmann, Anne</au><au>Weissert, Robert</au><au>Kanz, Lothar</au><au>Einsele, Hermann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>100</volume><issue>7</issue><spage>2679</spage><epage>2680</epage><pages>2679-2680</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12360984</pmid><doi>10.1182/blood-2002-07-2030</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2002-10, Vol.100 (7), p.2679-2680
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2002_07_2030
source ScienceDirect - Connect here FIRST to enable access
subjects Adult
Combined Modality Therapy
Drug Therapy, Combination
Humans
Ifosfamide - therapeutic use
Melphalan - therapeutic use
POEMS Syndrome - drug therapy
POEMS Syndrome - physiopathology
POEMS Syndrome - therapy
Prednisolone - therapeutic use
Stem Cell Transplantation
Time Factors
Transplantation, Autologous
Treatment Outcome
title Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood stem cell transplantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T19%3A08%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20follow-up%20on%20a%20patient%20with%20incomplete%20POEMS%20syndrome%20undergoing%20high-dose%20therapy%20and%20autologous%20blood%20stem%20cell%20transplantation&rft.jtitle=Blood&rft.au=Wiesmann,%20Anne&rft.date=2002-10-01&rft.volume=100&rft.issue=7&rft.spage=2679&rft.epage=2680&rft.pages=2679-2680&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2002-07-2030&rft_dat=%3Celsevier_cross%3ES0006497120573114%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2800-8b2599430ff3244ef22af7267fef21f2c8578abb82a332e7901319a8c14448263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/12360984&rfr_iscdi=true